Monocyte chemotactic S19 ribosomal protein dimer in atherosclerotic vascular lesion

Virchows Archiv

Volumn 447, Issue 4, 2005, Pages 747-755

  Shi, Lei ^a   Tsurusaki, Shigeyuki ^a   Futa, Noriko ^b   Sakamoto, Tamami ^b   Matsuda, Tomoko ^b   Nishino, Norikazu ^c   Kunitomo, Ryuji ^a   Kawasuji, Michio ^a   Tokita, Kazutaka ^a   Yamamoto, Tetsuro ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b TRANSGENIC INC   (Japan)

^c KYUSHU INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Atherosclerosis; C5a receptor; Leukocyte chemoattraction; Monocyte chemoattractant protein 1; S19 ribosomal protein

Indexed keywords

CD68 ANTIGEN; DIMER; MONOCLONAL ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN ANTIBODY; RIBOSOMAL PROTEIN S19; RIBOSOME PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTICLE; CELL INFILTRATION; CHEMOTAXIS; CONTROLLED STUDY; IMMUNOADSORPTION; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; INTIMA; MACROPHAGE MIGRATION; MALE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY AFFINITY; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CHEMOKINE CCL2; CHEMOTAXIS, LEUKOCYTE; CORONARY ARTERIOSCLEROSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; MONOCYTES; PEPTIDE FRAGMENTS; RABBITS; RECEPTOR, ANAPHYLATOXIN C5A; RECEPTORS, COMPLEMENT; RIBOSOMAL PROTEINS;

EID: 27644432501     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-005-0012-5     Document Type: Article

References (22)

1. Aquel NM, Ball RY, Waldman H, Mitchinson MJ (1985) Identification of macrophages and smooth muscle cells in human atherosclerosis using monoclonal amtibodies. J Pathol 146:197-204
2. Cianciolo GJ, Snyderman R (1981) Monocyte responsiveness to chemotactic stimuli in a property of subpopulation of cells that can respond to multiple chemoattractants. J Clin Invest 67:60-68
3. Edwards RJ, Singleton AM, Boobis AR, Davies DS (1989) Cross-reaction of antibodies to coupling groups used in the production of anti-peptide antibodies. J Immunol Methods 117:215-220
4. Fernandez HN, Henson PM, Otani A, Hugh TE (1978) Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions. J Immunol 120:109-115
5. Horino K, Nishiura H, Ohsako T, Shibuya Y, Hiraoka T, Kitamura N, Yamamoto T (1998) A monocyte chemotactic factor, S19 ribosomal protein dimer, in phagocytic clearance of apoptotic cells. Lab Invest 78:603-617
6. Kockx MM, Herman AG (1998) Apoptosis in atherogenesis: implications for plaque destabilization (review). Eur Heart J 19 (Suppl G):G23-G28
7. Kondoh N, Schweinfest CW, Henderson KW, Papas TS (1992) Differential expression of S19 ribosomal protein, laminin-binding protein, and human lymphocyte antigen class I messenger RNAs associated with colon carcinoma progression and differentiation. Cancer Res 52:791-796
8. Matsubara S, Yamamoto T, Tsuruta T, Takagi K, Kambara T (1991) Complement C4-derived monocyte-directed chemotaxis-inhibitory factor: a molecular mechanism to cause polymorphonuclear leukocyte-predominant infiltration in rheumatoid arthritis synovial cavities. Am J Pathol 138:1279-1291
9. Nishimura T, Horino K, Nishiura H, Shibuya Y, Hiraoka T, Tanase S, Yamamoto T (2001) Apoptotic cells of an epithelial cell line, AsPC-1, release monocyte chemotactic S19 ribosomal protein dimer. J Biochem 129:445-454
10. Nishiura H, Shibuya Y, Matsubara S, Tanase S, Kambara T, Yamamoto T (1996) Monocyte chemotactic factor in rheumatoid arthritis synovial tissue: probably a cross-linked derivative of S19 ribosomal protein. J Biol Chem 271:878-882
11. Nishiura H, Shibuya Y, Yamamoto T (1998) S19 ribosomal protein cross-linked dimer causes monocyte-predominant infiltration by means of molecular mimicry to complement C5a. Lab Invest 78:1615-1623
12. Nishiura H, Tanase S, Shibuya Y, Nishimura T, Yamamoto T (1999) Determination of the cross-linked residues in homodimerization of S19 ribosomal protein concomitant with exhibition of monocyte chemotactic activity. Lab Invest 79:915-923
13. Okura Y, Brink M, Itabe H, Scheidegger KJ, Kalangos A, Delafontaine P (2000) Oxidized low-density lipoprotein is associated with apoptosis of vascular smooth muscle cells in human atherosclerotic plaques. Circulation 102:2680-2686
14. Shibuya Y, Shiokawa M, Nishiura H, Nishimura T, Nishimura T, Nishino N, Okabe H, Takagi K, Yamamoto T (2001) Identification of receptor binding sites of monocyte chemotactic S19 ribosomal protein dimer. Am J Pathol 159:2293-2301
15. Shrestha A, Horino K, Nishiura H, Yamamoto T (1999) Acquired immune response as a consequence of the macrophage-dependent apoptotic cell clearance and role of the monocyte chemotactic S19 ribosomal protein dimer in this connection. Lab Invest 79:1629-1642
16. Shrestha A, Shiokawa M, Nishimura T, Nishiura H, Tanaka Y, Nishino N, Shibuya Y, Yamamoto T (2003) Switch moiety in agonist/antagonist dual effect of S19 ribosomal protein dimer on leukocyte chemotactic C5a receptor. Am J Pathol 162:1381-1388
17. Shrestha A, Shi L, Tanase S, Tsukamoto M, Nishino N, Tokita K, Yamamoto T (2004) Bacterial chaperon protein, Skp, induces leukocyte chemotaxis via C5a receptor. Am J Pathol 164:763-772
18. Takeya M, Yoshimura T, Leonard EJ, Takahashi K (1993) Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody. Human Pathol 24:534-539
19. Umeda Y, Shibuya Y, Semba U, Tokita K, Nishino N, Yamamoto T (2004) Guinea pig ribosomal protein as precursor of C5a receptor-directed monocyte-selected leukocyte chemotactic factor. Inflam Res 53:623-630
20. Watanabe T, Hirata M, Yoshikawa Y, Nagafuchi Y, Toyoshima H, Watanabe T (1985) Role of macrophages in atherosclerosis. Sequential observation of cholesterol-induced rabbit aortic lesions by the immunoperoxidase technique using monoclonal anti-macrophage antibody. Lab Invest 53:80-90
21. Yamamoto T (2000) Molecular mechanism of monocyte predominant infiltration in chronic inflammation: mediation by a novel monocyte chemotactic factor, S19 ribosomal protein dimer. Pathol Int 50:863-871
22. Ylä-Herttura S, Lipton BA, Rosenfeld ME, Särkioja T, Yoshimura T, Leonard EJ, Witztum JL, Steinberg D (1991) Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci U S A 88:5252-5256